REG - Santander UKGrp Hdgs - Publication of Final Terms

Banco Santander SAAnnouncement

12/02/2026 18:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260212:nRSL8385Sa&default-theme=true

RNS Number : 8385S  Santander UK Group Holdings PLC  12 February 2026

 

SANTANDER UK GROUP HOLDINGS PLC

€30 BILLION EURO MEDIUM TERM NOTE PROGRAMME

PUBLICATION OF FINAL TERMS - SERIES B-5017

 

The following final terms (the Final Terms) are available for viewing:

 

Issue of EUR 750,000,000 Senior Fixed Rate Reset Notes due 16 February 2034
(ISIN XS3295826559) (Series B-5017) (the Notes) by Santander UK Group Holdings
plc, under the €30 billion Euro Medium Term Note programme of Santander UK
Group Holdings plc and Santander UK plc (the Programme).

 

To view the full Final Terms document, please click on or paste the following
URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/8385S_1-2026-2-12.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8385S_1-2026-2-12.pdf)

 

A copy of the Final Terms has been submitted to the National Storage Mechanism
and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism. This website is not
provided for, nor is it directed at, U.S. persons or persons in the United
States. If you are a U.S. person, or you are viewing this page from the United
States, you should exit this section of the website.

 

For further information, please contact:

 

Funding, Asset Rotation and Investor Relations

Santander UK plc

2 Triton Square

Regent's Place

London NW1 3AN

Email: fair@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

EEA MiFID II/UK MiFIR professionals/ECPs only/No EEA or UK PRIIPS KID.

 

Please note that the information contained in the Final Terms and the
Prospectus published in respect of the Programme on 4 April 2025, as
supplemented on 30 April, 2025, 30 July 2025, 29 August 2025 and 4 February
2026 (together, the Prospectus) may be addressed to and/or targeted at persons
who are residents of particular countries only (as further specified in the
Prospectus) and is not intended for use and should not be relied upon by any
person outside these countries and/or to whom the offer contained in the Final
Terms and the Prospectus is not addressed. Prior to relying on the information
contained in the Final Terms and the Prospectus you must ascertain from the
Final Terms and the Prospectus whether or not you are part of the intended
addressees of the information contained therein.

 

Your right to access this service is conditional upon your compliance with the
above requirement.

 

This publication of the Final Terms does not constitute an offer of securities
for sale in the United States. The securities described herein have not been,
and will not be, registered under the U.S. Securities Act of 1933, as amended
(the Securities Act), or under any relevant securities laws of any state of
the United States of America, and may not be offered or sold in the United
States of America or to, or for the benefit of, U.S. persons (as defined in
Regulation S of the Securities Act), unless the securities are registered
under the Securities Act or an exemption from the registration requirements of
the Securities Act is available.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFTBRGDDBGBDGLD



            Copyright 2019 Regulatory News Service, all rights reserved